(Stroke. 1997;28:439-447.)
© 1997 American Heart Association, Inc.
Articles |
Neuroprotection With NBQX in Rat Focal Cerebral Ischemia
Effects on ADC Probability Distribution Functions and Diffusion-Perfusion Relationships
the Department of Radiology, the Center for Imaging and Pharmaceutical Research (E.H.L., A.R.P.), and the Nuclear Magnetic Resonance Center (J.B.M., B.R.R.), Massachusetts General Hospital, Harvard Medical School, Charlestown.
Correspondence to Eng H. Lo, PhD, Center for Imaging and Pharmaceutical Research, Harvard Medical School, MGH East Bldg 149, Charlestown, MA 02129. E-mail eng@cipr.mgh.harvard.edu.
Background and Purpose We have previously shown that treatment with glutamate receptor antagonists after focal ischemia can partially reverse acute lesions measured with diffusion-weighted MRI. The goal of this study was to examine the quantitative nature of these effects of neuroprotection.
Methods Rats were subjected to permanent occlusion of the middle cerebral artery under halothane anesthesia and treated with 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) (30 mg/kg IP; two doses given immediately after ischemia and 1 hour after ischemia) or given injections of saline. Diffusion-weighted MRI scans were performed to map the changes in water diffusivity during the first 3 hours after ischemia. Apparent diffusion coefficients (ADCs) within the ischemic hemisphere were calculated, and ischemic changes were expressed as absolute reductions and as a percentage of contralateral mean values. Relative perfusion deficits in the ischemic hemisphere were assessed with dynamic MRI of transient changes in transverse relaxation rates (
R2*).
Results Analysis with ADC probability distribution functions showed that focal ischemia was present with gradients in ADC reductions emanating from the center to the periphery of the lesion. Ischemic evolution in control rats was manifested as a progressive shift of the probability distribution functions over time. NBQX treatment resulted in a reverse shift of these probability functions. By 3 hours after occlusion, probability distribution functions were significantly improved in treated rats (P<.05). Because of the temporal evolution of the probability distribution functions, ADC thresholds that correlated with histological outcomes of infarction changed over time. NBQX did not alter the cerebral perfusion index, measured as R2* peak values.
Conclusions The results indicate that ADC probability distribution functions can be used to quantitatively evaluate the effects of neuroprotective treatment on the gradients of injury in focal cerebral ischemia. The probability functions also allow for intrasubject comparisons and may therefore be useful for exploring therapeutic windows.
Editorial Comment
Effects on ADC Probability Distribution Functions and Diffusion-Perfusion Relationships
Department of Neurology and Mallinkrodt Institute of RadiologyWashington University School of MedicineSt Louis, Mo
This article has been cited by other articles:
 |
|
 |
|
  F CHEN, Q LIU, H WANG, Y SUZUKI, N NAGAI, J YU, G MARCHAL, and Y NI Comparing two methods for assessment of perfusion-diffusion mismatch in a rodent model of ischaemic stroke: a pilot study Br. J. Radiol., March 1, 2008; 81(963): 192 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Lansberg, V. N. Thijs, M. W. O'Brien, J. O. Ali, A. J. de Crespigny, D. C. Tong, M. E. Moseley, and G. W. Albers Evolution of Apparent Diffusion Coefficient, Diffusion-weighted, and T2-weighted Signal Intensity of Acute Stroke AJNR Am. J. Neuroradiol., April 1, 2001; 22(4): 637 - 644. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Mukherjee, M. M. Bahn, R. C. McKinstry, J. S. Shimony, T. S. Cull, E. Akbudak, A. Z. Snyder, and T. E. Conturo Differences between Gray Matter and White Matter Water Diffusion in Stroke: Diffusion-Tensor MR Imaging in 12 Patients Radiology, April 1, 2000; 215(1): 211 - 220. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. W. Albers Expanding the Window for Thrombolytic Therapy in Acute Stroke : The Potential Role of Acute MRI for Patient Selection Stroke, October 1, 1999; 30(10): 2230 - 2237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Schielke, N. C. Kupina, P. A. Boxer, C. F. Bigge, D. F. Welty, and C. Iadecola The Neuroprotective Effect of the Novel AMPA Receptor Antagonist PD152247 (PNQX) in Temporary Focal Ischemia in the Rat • Editorial Comment Stroke, July 1, 1999; 30(7): 1472 - 1477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fisher and G. W. Albers Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke Neurology, June 1, 1999; 52(9): 1750 - 1750. [Abstract] [Full Text]
|
|
|
|
|
|
M. Shimizu-Sasamata, T. Kano, J. Rogowska, G. L. Wolf, M. A. Moskowitz, E. H. Lo, and C. Iadecola YM872, a Highly Water-Soluble AMPA Receptor Antagonist, Preserves the Hemodynamic Penumbra and Reduces Brain Injury After Permanent Focal Ischemia in Rats • Editorial Comment Stroke, October 1, 1998; 29(10): 2141 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Lo, P. Bosque-Hamilton, W. Meng, and N. Panahian Inhibition of Poly(ADP-Ribose) Polymerase : Reduction of Ischemic Injury and Attenuation of N-Methyl-D-Aspartate–Induced Neurotransmitter Dysregulation • Editorial Comment: Reduction of Ischemic Injury and Attenuation of N-Methyl-D-Aspartate–Induced Neurotransmitter Dysregulation Stroke, April 1, 1998; 29(4): 830 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tatlisumak, R. A. D. Carano, K. Takano, T. J. Opgenorth, C. H. Sotak, M. Fisher, C. Y. Hsu, and W. Lin A Novel Endothelin Antagonist, A-127722, Attenuates Ischemic Lesion Size in Rats With Temporary Middle Cerebral Artery Occlusion : A Diffusion and Perfusion MRI Study • Editorial Comment: A Diffusion and Perfusion MRI Study Stroke, April 1, 1998; 29(4): 850 - 858. [Abstract] [Full Text] [PDF]
|
|